Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre

BACKGROUND Idiopathic pulmonary fibrosis (IPF) differs substantially from other idiopathic interstitial pneumonias regarding disease trajectory and the appropriate management strategies, making meticulous diagnosis essential. However, patient characteristics and clinical practice vary be...

Full description

Bibliographic Details
Main Authors: Sabina A. Guler, Pascal Zumstein, Sabina Berezowska, Alexander Poellinger, Thomas Geiser, Manuela Funke-Chambour
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2018-01-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/2427
_version_ 1798003628341985280
author Sabina A. Guler
Pascal Zumstein
Sabina Berezowska
Alexander Poellinger
Thomas Geiser
Manuela Funke-Chambour
author_facet Sabina A. Guler
Pascal Zumstein
Sabina Berezowska
Alexander Poellinger
Thomas Geiser
Manuela Funke-Chambour
author_sort Sabina A. Guler
collection DOAJ
description BACKGROUND Idiopathic pulmonary fibrosis (IPF) differs substantially from other idiopathic interstitial pneumonias regarding disease trajectory and the appropriate management strategies, making meticulous diagnosis essential. However, patient characteristics and clinical practice vary between clinical trials, and real life and registries provide the opportunity to critically analyse current clinical practices in order to ultimately improve patient care. ​ METHODS: We aimed to identify characteristics of our baseline IPF cohort at initiation of a web-based registry for patients with idiopathic interstitial pneumonia. Baseline and 6-month follow-up data from all consecutive IPF patients consulting at our centre over 2 years were analysed. RESULTS Forty IPF patients were included for baseline and 23 for longitudinal analysis. Besides many similarities to other IPF populations, our cohort included considerably fewer women. Forced vital capacity impairment in our cohort was more severe and mortality prediction poorer than in clinical trials, which emphasises the importance to confirm the applicability of clinical trial results with data from real life settings. CONCLUSION Registries for rare diseases such as IPF are a valuable resource for studying the course of the disease under current compliance with diagnostic and treatment guidelines and to appreciate local epidemiological particularities.
first_indexed 2024-04-11T12:12:05Z
format Article
id doaj.art-b6b16cad89aa4f72a2685d3c028d6666
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2024-04-11T12:12:05Z
publishDate 2018-01-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-b6b16cad89aa4f72a2685d3c028d66662022-12-22T04:24:36ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972018-01-01148010210.4414/smw.2018.14577Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centreSabina A. Guler0Pascal Zumstein1Sabina Berezowska2Alexander Poellinger3Thomas Geiser4Manuela Funke-Chambour5Department of Pulmonary Medicine, University Hospital and University of Bern, SwitzerlandDepartment of Pulmonary Medicine, University Hospital and University of Bern, SwitzerlandInstitute of Pathology, University of Bern, SwitzerlandDepartment of Diagnostic, Interventional and Paediatric Radiology, University Hospital and University of Bern, SwitzerlandDepartment of Pulmonary Medicine, University Hospital and University of Bern, SwitzerlandDepartment of Pulmonary Medicine, University Hospital and University of Bern, Switzerland BACKGROUND Idiopathic pulmonary fibrosis (IPF) differs substantially from other idiopathic interstitial pneumonias regarding disease trajectory and the appropriate management strategies, making meticulous diagnosis essential. However, patient characteristics and clinical practice vary between clinical trials, and real life and registries provide the opportunity to critically analyse current clinical practices in order to ultimately improve patient care. ​ METHODS: We aimed to identify characteristics of our baseline IPF cohort at initiation of a web-based registry for patients with idiopathic interstitial pneumonia. Baseline and 6-month follow-up data from all consecutive IPF patients consulting at our centre over 2 years were analysed. RESULTS Forty IPF patients were included for baseline and 23 for longitudinal analysis. Besides many similarities to other IPF populations, our cohort included considerably fewer women. Forced vital capacity impairment in our cohort was more severe and mortality prediction poorer than in clinical trials, which emphasises the importance to confirm the applicability of clinical trial results with data from real life settings. CONCLUSION Registries for rare diseases such as IPF are a valuable resource for studying the course of the disease under current compliance with diagnostic and treatment guidelines and to appreciate local epidemiological particularities. https://www.smw.ch/index.php/smw/article/view/2427idiopathic interstitial pneumoniaidiopathic pulmonary fibrosisregistryreal life practiceCohort study
spellingShingle Sabina A. Guler
Pascal Zumstein
Sabina Berezowska
Alexander Poellinger
Thomas Geiser
Manuela Funke-Chambour
Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
Swiss Medical Weekly
idiopathic interstitial pneumonia
idiopathic pulmonary fibrosis
registry
real life practice
Cohort study
title Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
title_full Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
title_fullStr Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
title_full_unstemmed Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
title_short Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
title_sort idiopathic pulmonary fibrosis in a swiss interstitial lung disease reference centre
topic idiopathic interstitial pneumonia
idiopathic pulmonary fibrosis
registry
real life practice
Cohort study
url https://www.smw.ch/index.php/smw/article/view/2427
work_keys_str_mv AT sabinaaguler idiopathicpulmonaryfibrosisinaswissinterstitiallungdiseasereferencecentre
AT pascalzumstein idiopathicpulmonaryfibrosisinaswissinterstitiallungdiseasereferencecentre
AT sabinaberezowska idiopathicpulmonaryfibrosisinaswissinterstitiallungdiseasereferencecentre
AT alexanderpoellinger idiopathicpulmonaryfibrosisinaswissinterstitiallungdiseasereferencecentre
AT thomasgeiser idiopathicpulmonaryfibrosisinaswissinterstitiallungdiseasereferencecentre
AT manuelafunkechambour idiopathicpulmonaryfibrosisinaswissinterstitiallungdiseasereferencecentre